Cancer Immunotherapy: The Way to Nobel Prize in Medicine

Tehran University of Medical Sciences

Science Communicator Platform

Share By

Cancer Immunotherapy: The Way to Nobel Prize in Medicine

Rayzan E^{1, 2} ; Rezaei N^{1, 3, 4}

Source: Acta Medica Iranica Published:2018

Abstract

[No abstract available]

Related Docs

1. Pd-1/Pd-L1 Pathway: Basic Biology and Role in Cancer Immunotherapy, Journal of Cellular Physiology (2019)

Style	Citing Format
MLA	Rayzan E, Rezaei N. "Cancer Immunotherapy: The Way to Nobel Prize in Medicine." Acta Medica Iranica, vol. 56, no. 10, 2018, pp. 623-624.
APA	Rayzan E, Rezaei N (2018). Cancer Immunotherapy: The Way to Nobel Prize in Medicine. Acta Medica Iranica, 56(10), 623-624.
Chicago	Rayzan E, Rezaei N. "Cancer Immunotherapy: The Way to Nobel Prize in Medicine." Acta Medica Iranica 56, no. 10 (2018): 623-624.
Harvard	Rayzan E, Rezaei N (2018) 'Cancer Immunotherapy: The Way to Nobel Prize in Medicine', Acta Medica Iranica, 56(10), pp. 623-624.
Vancouver	Rayzan E, Rezaei N. Cancer Immunotherapy: The Way to Nobel Prize in Medicine. Acta Medica Iranica. 2018;56(10):623-624.
BibTex	@article{ author = {Rayzan E and Rezaei N}, title = {Cancer Immunotherapy: The Way to Nobel Prize in Medicine}, journal = {Acta Medica Iranica}, volume = {56}, number = {10}, pages = {623-624}, year = {2018} }
RIS	TY - JOUR AU - Rayzan E AU - Rezaei N TI - Cancer Immunotherapy: The Way to Nobel Prize in Medicine JO - Acta Medica Iranica VL - 56 IS - 10 SP - 623 EP - 624 PY - 2018 ER -